Detalhe da pesquisa
1.
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.
Gastroenterology
; 163(5): 1407-1422, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35870514
2.
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma.
Cells
; 10(7)2021 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359990